284
Views
29
CrossRef citations to date
0
Altmetric
Obesity

Adiponectin attenuates human eosinophil adhesion and chemotaxis: implications in allergic inflammation

, BS, , MD, PhD, , MD, PhD, , MD, PhD, , PhD, , DDS, , MD, , MD, , MD, PhD, , MD, PhD & , MD, PhD show all
Pages 828-835 | Received 22 Jan 2013, Accepted 13 Jun 2013, Published online: 17 Jul 2013

References

  • Taylor B, Mannino D, Brown C, Crocker D, Twum-Baah N, Holguin F. Body mass index and asthma severity in the National Asthma Survey. Thorax 2008;63:14–20
  • Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007;175:661–666
  • Chinn S, Jarvis D, Burney P. Relation of bronchial responsiveness to body mass index in the ECRHS. European Community Respiratory Health Survey. Thorax 2002;57:1028–1033
  • Litonjua AA, Sparrow D, Celedon JC, DeMolles D, Weiss ST. Association of body mass index with the development of methacholine airway hyperresponsiveness in men: the Normative Aging Study. Thorax 2002;57:581–585
  • Sood A, Verhulst SJ, Varma A, Eagleton LE, Henkle JQ, Hopkins-Price P. Association of excess weight and degree of airway responsiveness in asthmatics and non-asthmatics. J Asthma 2006;43:447–452
  • Boulet LP, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 2007;101:2240–2247
  • Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006;27:495–503
  • Stenius-Aarniala B, Poussa T, Kvarnstrom J, Gronlund EL, Ylikahri M, Mustajoki P. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 2000;320:827–832
  • Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911–919 (quiz 20)
  • Takeda M, Ueki S, Kato H, Konno Y, Chihara M, Itoga M, Kobayashi Y, et al. Obesity and eosinophilic inflammation: does leptin play a role. Int Arch Allergy Immunol 2012;158:87–91
  • Okamoto Y, Folco EJ, Minami M, Wara AK, Feinberg MW, Sukhova GK, Colvin RA, et al. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ Res 2008;102:218–225
  • Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, Okada-Iwabu M, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 2007;13:332–339
  • Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, Miller LC, Orlova C, Mantzoros CS. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 2003;88:4823–4831
  • Tsai JS, Chen CY, Chen YL, Chuang LM. Rosiglitazone inhibits monocyte/macrophage adhesion through de novo adiponectin production in human monocytes. J Cell Biochem 2010;110:1410–1419
  • Sood A, Qualls C, Schuyler M, Thyagarajan B, Steffes MW, Smith LJ, Jacobs DR. Low serum adiponectin predicts future risk for asthma in women. Am J Respir Crit Care Med 2012;186:41–47
  • Hsueh KC, Lin YJ, Lin HC, Lin CY. Serum leptin and adiponectin levels correlate with severity of allergic rhinitis. Pediatr Allergy Immunol 2010;21:e155–159
  • Shore SA, Terry RD, Flynt L, Xu A, Hug C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol 2006;118:389–395
  • Medoff BD, Okamoto Y, Leyton P, Weng M, Sandall BP, Raher MJ, Kihara S, et al. Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am J Respir Cell Mol Biol 2009;41:397–406
  • Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006;24:147–174
  • Kita H. Eosinophils: multifaceted biological properties and roles in health and disease. Immunol Rev. 2011;242:161–177
  • Kato H, Ueki S, Kamada R, Kihara J, Yamauchi Y, Suzuki T, Takeda M, et al. Leptin has a priming effect on eotaxin-induced human eosinophil chemotaxis. Int Arch Allergy Immunol 2011;155:335–344
  • Ueki S, Kihara J, Kato H, Ito W, Takeda M, Kobayashi Y, Kayaba H, et al. Soluble vascular cell adhesion molecule-1 induces human eosinophil migration. Allergy 2009;64:718–724
  • Ueki S, Mahemuti G, Oyamada H, Kato H, Kihara J, Tanabe M, Ito W, et al. Retinoic acids are potent inhibitors of spontaneous human eosinophil apoptosis. J Immunol. 2008;181:7689–7698
  • Hirasawa H, Chiba T, Ueki S, Kamada Y, Ito W, Takeda M, Fujita M, et al. The synthetic PPARgamma agonist troglitazone inhibits eotaxin-enhanced eosinophil adhesion to ICAM-1-coated plates. Int Arch Allergy Immunol 2008;146:11–15
  • Tanigai T, Ueki S, Kihara J, Kamada R, Yamauchi Y, Sokal A, Takeda M, et al. Docosahexaenoic acid exerts anti-inflammatory action on human eosinophils through Peroxisome Proliferator-Activated Receptor-independent mechanisms. Int Arch Allergy Immunol 2012;158:375–386
  • Ito W, Chiba T, Kanehiro A, Kato H, Yamaguchi K, Ueki S, Kayaba H, et al. Hepatocyte growth factor attenuates eotaxin and PGD2-induced chemotaxis of human eosinophils. Allergy 2007;62:415–422
  • Pang TT, Narendran P. The distribution of adiponectin receptors on human peripheral blood mononuclear cells. Ann N Y Acad Sci 2008;1150:143–145
  • Kollias A, Tsiotra PC, Ikonomidis I, Maratou E, Mitrou P, Kyriazi E, Boutati E, et al. Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease. Cardiovasc Diabetol 2011;10:14.
  • Nitta N, Tsuchiya T, Yamauchi A, Tamatani T, Kanegasaki S. Quantitative analysis of eosinophil chemotaxis tracked using a novel optical device – TAXIScan. J Immunol Methods 2007;320:155–163
  • Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK, Chawla A, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011;332:243–247
  • Mahadev K, Wu X, Donnelly S, Ouedraogo R, Eckhart AD, Goldstein BJ. Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovasc Res 2008;78:376384
  • Saito N, Yamada Y, Sannohe S, Honda K, Adachi T, Kayaba H, Chihara J, et al. Possible involvement of C-C chemokines in functional augmentation of adhesion molecules in asthmatic patients. Lung 2002;180:251–263
  • Manes S, Gomez-Mouton C, Lacalle RA, Jimenez-Baranda S, Mira E, Martinez AC. Mastering time and space: immune cell polarization and chemotaxis. Semin Immunol 2005;17:77–86
  • Tenscher K, Metzner B, Schopf E, Norgauer J, Czech W. Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. Blood 1996;88:3195–3199
  • Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, Kassam N, Smith H, et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996;97:604–612
  • Cottam DR, Schaefer PA, Shaftan GW, Velcu L, Angus LD. Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity. Obes Surg 2002;12:335–342
  • Shim WS, Kim HJ, Kang ES, Ahn CW, Lim SK, Lee HC, Cha BS. The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. Diabetes Res Clin Pract 2006;73:284–291
  • van Veen IH, Ten Brinke A, Sterk PJ, Rabe KF, Bel EH. Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy 2008;63:570–574
  • Calixto MC, Lintomen L, Schenka A, Saad MJ, Zanesco A, Antunes E. Obesity enhances eosinophilic inflammation in a murine model of allergic asthma. Br J Pharmacol 2010;159:617–625
  • Shore SA. Obesity, airway hyperresponsiveness, and inflammation. J Appl Physiol 2010;108:735–743
  • Richards DB, Bareille P, Lindo EL, Quinn D, Farrow SN. Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: a randomised controlled trial. Respir Med 2010;104:668–674
  • Spears M, Donnelly I, Jolly L, Brannigan M, Ito K, McSharry C, Lafferty J, et al. Bronchodilatory effect of the PPAR-gamma agonist rosiglitazone in smokers with asthma. Clin Pharmacol Ther 2009;86:49–53

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.